LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Erste Asset Management GmbH's Holding History (CIK: 0002024532)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 54,000 Value ($000) $82 Avg Close Range
Q2 2024
Shares 54,000 Value ($000) $75 Avg Close Range
Q1 2024
Shares 54,000 Value ($000) $110 Avg Close Range
Q4 2023
Shares 54,000 Value ($000) $114 Avg Close Range
Q3 2023
Shares 54,000 Value ($000) $85 Avg Close Range
Q2 2023
Shares 54,000 Value ($000) $169 Avg Close Range
Q1 2023
Shares 54,000 Value ($000) $116 Avg Close Range
Q4 2022
Shares 54,000 Value ($000) $178 Avg Close Range
Q3 2022
Shares 54,000 Value ($000) $400 Avg Close Range
Q2 2022
Shares 54,000 Value ($000) $362 Avg Close Range
Q1 2022
Shares 54,000 Value ($000) $289 Avg Close Range